Cargando…
When Clinical Trials Are Compromised: A Perspective from a Patient Advocate
In her personal essay, Mayer argues that many trained patient advocates are just as concerned as health professionals are with getting the very best evidence from clinical trials.
Autor principal: | Mayer, Musa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1255762/ https://www.ncbi.nlm.nih.gov/pubmed/16220998 http://dx.doi.org/10.1371/journal.pmed.0020358 |
Ejemplares similares
-
Terri Grodzicker: advocate and influencer of impactful science
por: Berger, Shelley L.
Publicado: (2023) -
Going Beyond Compromises in Multifunctionality of Biomaterials
por: Neffe, Axel T, et al.
Publicado: (2015) -
When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial?
por: Evans, Scott
Publicado: (2007) -
When the sun rises
por: Grazionale, Karen
Publicado: (2023) -
Translation of the focus toward excellence in translational science: comment on “TDP-43 Repression of Nonconserved Cryptic Exons is Compromised in ALS-FTD”
por: Pochet, Roland, et al.
Publicado: (2015)